Affordable Access

Publisher Website

Target organ damage: how to detect it and how to treat it?

Publication Date
DOI: 10.1097/01.hjh.0000356767.24507.8d
  • Atherosclerosis/Diagnosis
  • Atherosclerosis/Therapy
  • Cardiovascular Diseases/Diagnosis
  • Cardiovascular Diseases/Therapy
  • Chronic Disease
  • Echocardiography
  • Electrocardiography
  • Humans
  • Hypertension/Complications
  • Hypertension/Drug Therapy
  • Hypertrophy
  • Left Ventricular/Diagnosis
  • Hypertrophy
  • Left Ventricular/Therapy
  • Kidney Diseases/Diagnosis
  • Kidney Diseases/Therapy
  • Risk Factors
  • Medicine


The early detection of cardiac organ damage in clinical practice is primordial for cardiovascular risk profiling of patients with hypertension. In this respect the determination of microalbuminuria is very appealing because it increasingly appears to be the most cost-effective means to identify cardiovascular and renal complications. Considering the treatment of patients with target organ damage, blockers of the renin-angiotensin system have a key position as they are very effective in regressing left ventricular hypertrophy, lowering urinary albumin excretion and delaying the progression of nephropathy. In high-risk patients with atherosclerosis, the use of a blocker of the renin-angiotensin system is also appealing, and it appears increasingly judicious to combine such a blocker with a calcium antagonist whenever required to control blood pressure.

There are no comments yet on this publication. Be the first to share your thoughts.